[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100605342":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":22,"responsibleParty":37,"collaborators":10,"id":42,"slug":43,"hasResults":44,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":10,"eligibilityCriteria":48,"healthyVolunteers":44,"sex":49,"minAge":50,"maxAge":10,"enrollmentInfo":51,"targetDuration":10,"studyType":54,"phases":10,"briefSummary":55,"conditions":56,"keywords":61,"overallStatus":25,"whyStopped":10,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":74},{"fullName":5,"class":6},"Hong Kong University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Patients with respiratory failure and supported with ECCO2R",null,"Patients supported with ECCO2R in one of the designated study sites; Admitted to the ICU between 1 Jan 2022 and 30 June 2024; Patients older than 18 years old",[13,18],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},"Wai Ching Simon Sin, Director, Clinical Professor","CONTACT","(852)9090-8772","drwcsin@hku.hk",{"name":19,"role":15,"phone":20,"phoneExt":10,"email":21},"SI CHEN, Master","(852)54630558","cyn08ccs@hku.hk",[23],{"facility":24,"status":25,"city":26,"state":10,"zip":10,"country":26,"countryCode":27,"cosmosGeoPoint":28,"geoPoint":33,"contacts":34},"Queen Mary Hospital (QMH)","RECRUITING","Hong Kong","HK",{"type":29,"coordinates":30},"Point",[31,32],114.17469,22.27832,{"lat":32,"lon":31},[35],{"name":14,"role":15,"phone":36,"phoneExt":10,"email":17},"(852) 9090-8772",{"type":38,"investigatorFullName":39,"investigatorTitle":40,"investigatorAffiliation":41,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Simon Sin Wai-ching","Doctor; Director and Clinical Associate Professor","Hospital Authority, Hong Kong","100605342","retrospective-cohort-study-of-low-flow-extracorporeal-carbon-dioxide-removal-ecco2r-system-evaluating-ecco2rs-efficacy-and-safety-in-participants-with-respiratory-failure-100605342",false,"NCT07161271","Retrospective Cohort Study of Low-Flow Extracorporeal Carbon Dioxide Removal (ECCO2R) System: Evaluating ECCO2R's Efficacy and Safety in Participants With Respiratory Failure","Retrospective Cohort Study of Low-Flow Extracorporeal Carbon Dioxide Removal (ECCO2R) System: Evaluating Efficacy and Safety","Inclusion Criteria:\n\n* Patients supported with ECCO2R in one of the designated study sites\n* Admitted to the ICU between 1 Jan 2022 and 30 June 2024\n\nExclusion Criteria:\n\n* Patients younger than 18 years old","ALL","18 Years",{"count":52,"type":53},59,"ESTIMATED","OBSERVATIONAL","This is an observational study performed by retrospective review of data routinely collected for patients receiving low-flow extracorporeal carbon dioxide removal (ECCO2R) therapy in intensive care units (ICUs). Our aim is to firstly, describe the local practice in terms of patient selection and technical details of clinical management related to the use of low-flow ECCO2R system, and secondly, the clinical results in terms of patient outcomes and adverse events. These findings may allow clinicians to improve the quality and safety of ECCO2R therapy provision in the ICU.",[57,58,59,60],"Respiratory Failure","ICU","Asthma (Diagnosis)","ARDS",[62,58,63,60,64],"ECCO2R","Asthma","Respiratory failure","2025-12-22",{"date":67,"type":68},"2025-12-23","ACTUAL",{"date":70,"type":68},"2024-11-01",{"date":72,"type":53},"2027-06-30",{"name":5,"class":6},1]